These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2151488)

  • 1. Simulation of human pharmacokinetic profiles in mice, and impact on antimicrobial efficacy of netilmicin, ticarcillin and ceftazidime in the peritonitis-septicemia model.
    Gerber AU; Stritzko T; Segessenmann C; Stalder B
    Scand J Infect Dis Suppl; 1990; 74():195-203. PubMed ID: 2151488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of the pre-treatment interval on antimicrobial efficacy in a biological model.
    Gerber AU; Greter U; Segessenmann C; Kozak S
    J Antimicrob Chemother; 1993 May; 31 Suppl D():29-39. PubMed ID: 8335522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudomonas peritonitis in neutropenic rats treated with amikacin, ceftazidime and ticarcillin, alone and in combination.
    Shyu WC; Nightingale CH; Quintiliani R
    J Antimicrob Chemother; 1987 Jun; 19(6):807-14. PubMed ID: 3112102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic therapy of infections due to Pseudomonas aeruginosa in normal and granulocytopenic mice: comparison of murine and human pharmacokinetics.
    Gerber AU; Brugger HP; Feller C; Stritzko T; Stalder B
    J Infect Dis; 1986 Jan; 153(1):90-7. PubMed ID: 3510263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-daily versus thrice-daily administration of netilmicin in combination therapy of Pseudomonas aeruginosa infection in a man-adapted neutropenic animal model.
    Gerber AU; Kozak S; Segessenmann C; Flückiger U; Bangerter T; Greter U
    Eur J Clin Microbiol Infect Dis; 1989 Mar; 8(3):233-7. PubMed ID: 2496992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and bactericidal activity of a single daily dose of netilmicin in the treatment of CAPD-associated peritonitis.
    Anding K; Krumme B; Pelz K; Böhler J; Schollmeyer P
    Int J Clin Pharmacol Ther; 1996 Nov; 34(11):465-9. PubMed ID: 8937927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftazidime versus tobramycin-ticarcillin in the treatment of pneumonia and bacteremia.
    Cone LA; Woodard DR; Stoltzman DS; Byrd RG
    Antimicrob Agents Chemother; 1985 Jul; 28(1):33-6. PubMed ID: 3899005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simulation of human serum pharmacokinetics of ticarcillin-clavulanic acid and ceftazidime in rabbits, and efficacy against experimental Klebsiella pneumoniae meningitis.
    Mizen L; Woodnutt G; Kernutt I; Catherall EJ
    Antimicrob Agents Chemother; 1989 May; 33(5):693-9. PubMed ID: 2665641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of netilmicin-ticarcillin and tobramycin-ticarcillin in the treatment of serious systemic infections in elderly patients.
    Jansen W; Schwarz A
    Clin Ther; 1984; 7(1):112-20. PubMed ID: 6394127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial therapy of Pseudomonas pulmonary exacerbations in cystic fibrosis. A prospective evaluation of netilmicin plus azlocillin versus netilmicin plus ticarcillin.
    Schaad UB; Desgrandchamps D; Kraemer R
    Acta Paediatr Scand; 1986 Jan; 75(1):128-38. PubMed ID: 3082103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single versus combination antibiotic therapy for pneumonia due to Pseudomonas aeruginosa in neutropenic guinea pigs.
    Rusnak MG; Drake TA; Hackbarth CJ; Sande MA
    J Infect Dis; 1984 Jun; 149(6):980-5. PubMed ID: 6429255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of dosing intervals on activity of gentamicin and ticarcillin against Pseudomonas aeruginosa in granulocytopenic mice.
    Gerber AU; Craig WA; Brugger HP; Feller C; Vastola AP; Brandel J
    J Infect Dis; 1983 May; 147(5):910-7. PubMed ID: 6842025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefazolin plus netilmicin versus cefazolin plus ceftazidime for treating CAPD peritonitis: effect on residual renal function.
    Lui SL; Cheng SW; Ng F; Ng SY; Wan KM; Yip T; Tse KC; Lam MF; Lai KN; Lo WK
    Kidney Int; 2005 Nov; 68(5):2375-80. PubMed ID: 16221243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bolus injection, short infusion or intravenous drip of aminoglycoside antibiotics? In vivo study with netilmicin and Pseudomonas aeruginosa].
    Brugger HP; Gerber AU; Feller-Segessenmann C
    Schweiz Med Wochenschr; 1983 Dec; 113(49):1858-60. PubMed ID: 6427922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftazidime/metronidazole versus netilmicin/metronidazole in the treatment of perforated appendicitis in children.
    Kooi GH; Pit S
    Clin Ther; 1990; 12(1):54-60. PubMed ID: 2183940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of netilmicin regimens on the activities of ceftazidime-netilmicin combinations against Pseudomonas aeruginosa in an in vitro pharmacokinetic model.
    Blaser J; Stone BB; Groner MC; Zinner SH
    Antimicrob Agents Chemother; 1985 Jul; 28(1):64-8. PubMed ID: 3929682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethics of drug studies in infants: how many samples are required for accurate estimation of pharmacokinetic parameters in neonates?
    Long D; Koren G; James A
    J Pediatr; 1987 Dec; 111(6 Pt 1):918-21. PubMed ID: 3316566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of resistance during ceftazidime and cefepime therapy in a murine peritonitis model.
    Pechère JC; Vladoianu IR
    J Antimicrob Chemother; 1992 May; 29(5):563-73. PubMed ID: 1624394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of complicated urinary tract infection caused by Pseudomonas aeruginosa--a comparison of the efficacy of ceftazidime with that of netilmicin.
    Graninger W; Ho I; Francesconi M; Schmidbauer C; Egger T
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():323-4. PubMed ID: 19803008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive treatment of pseudomonas chest infection in cystic fibrosis: a comparison of tobramycin and ticarcillin, and netilmicin and ticarcillin.
    Conway SP; Miller MG; Ramsden C; Littlewood JM
    Acta Paediatr Scand; 1985 Jan; 74(1):107-13. PubMed ID: 3885674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.